The Daily Courier

Does vaccine increase Guillain-Barre risk?

- KEITH ROACH

DEAR DR. ROACH: I am asking for a restatemen­t/clarificat­ion of your position on flu shots for those who have had autoimmune disorders.

I am a 69-year-old male who suffered an attack of Guillain-Barre syndrome in 1973. I have residual neurologic­al and muscular damage, but otherwise I am in excellent health. I have declined the flu shot up to this point, based on the recommenda­tion of my doctor and the advice given at sites where flu shots are offered.

I have always questioned this advice. Caught between the Scylla of risking a recurrence of Guillain-Barre and the Charybdis of dying of the flu, it seems to me that Scylla is the better bet.

ANSWER: Guillain-Barre syndrome is an immune-mediated neurologic­al disease causing paralysis, usually as a result of an infection. It’s thought that the infection tricks the body into thinking that part of your body is an invader that needs to be destroyed. In the case of GBS, it’s the nerve cell — or the myelin, a protein that protects and insulates the cells — that is the target of the immune system.

Although people have developed GBS after vaccinatio­n, the risk is very low (unlikely to be more than two per million), and some studies have suggested that there is no increase in risk following vaccinatio­n.

However, many experts recommend against influenza vaccinatio­n in those people who developed GBS within six weeks of getting the vaccine.

Odysseus tried to sail exactly between Scylla (a six-headed monster) and Charybdis (a whirlpool), but you can’t go between — you must choose whether or not to get the vaccine. Here’s what studies have shown:

Among 107 people who chose to get the vaccine after having had GBS, none had a recurrence of GBS. Another study with 279 patients also showed zero episodes of recurrent GBS. This does not mean there is no risk, but the risk probably is very low.

Getting the flu vaccine (partially) protects you from dying of the flu, but the absolute reduction in death rate is small. In older people, perhaps a single vaccinated person is saved per 200-300; other estimates are not that high.

It’s very difficult to make a decision about competing low-risk events. You probably will be fine either way. Given a more likely benefit of vaccinatio­n against only a lesser possibilit­y of harm from GBS would argue for getting the vaccine; however, this remains controvers­ial.

DEAR DR. ROACH: While stationed in the U.S. in 1967, I volunteere­d for a “study” in which an amount of my blood was collected, then saved and returned to my veins. I can’t believe as a stupid 19-year-old I trusted some military individual to return my blood to me, and apparently didn’t think of the risks involved. I suppose the prospect of receiving what equaled 25 percent of my monthly pittance was my main draw.

ANSWER: Protection for subjects in scientific studies has improved since 1967, especially for people in whom compulsion is more likely, such as military, prisoners and medical students, all of whom have been famously involved in research studies.

It’s also possible that lives have been saved thanks to people like you who participat­ed in this study. We actually do this procedure now in clinical practice. People will have a unit or two of blood removed, and then they can get their own blood back during or after surgery. I suspect the military was testing that back in 1967.

It seems unlikely, now that you are 70 (or near there), that it led to any medical issues.

Readers may email questions to ToYourGood­Health@med.cornell.edu.

 ??  ??

Newspapers in English

Newspapers from Canada